The salmonella typhi vaccine protects against typhoid fever, a severe bacterial infection caused by Salmonella Typhi. It is recommended for travelers to areas with poor sanitation and for people in high-risk occupational settings.
Salmonella Typhi lives only in humans and spreads through contaminated food or water. The bacteria invade the intestinal lining and enter the bloodstream, causing prolonged fever, headache, abdominal pain, and sometimes rash. Without treatment, complications like intestinal bleeding or perforation can occur. The vaccine reduces risk by targeting the bacterium's outer capsule or live attenuated strains.
Two licensed formulations exist: the injectable Vi capsular polysaccharide vaccine and the oral Ty21a vaccine. Both are effective but differ in administration, duration of protection, and suitability for certain populations. The World Health Organization (WHO) recommends typhoid vaccination for travelers to endemic regions such as India, Pakistan, Bangladesh, and parts of Southeast Asia and sub-Saharan Africa.
The injectable Vi vaccine contains purified capsular polysaccharide from the bacterium's outer coat. This component triggers an immune response without causing disease. The body produces antibodies that neutralize the bacteria upon exposure. Protection begins about 14 days after injection and lasts at least two years, though some evidence suggests longer immunity.
The oral Ty21a vaccine uses live, attenuated S. Typhi bacteria grown in a lab. These weakened strains replicate briefly in the gut, stimulating mucosal and systemic immunity. Because it mimics natural infection, it provides stronger local immunity in the intestines-the primary site of invasion. The oral version requires four capsules taken on alternate days, with the last dose at least one week before travel.
A key difference lies in booster requirements. The injectable vaccine needs a booster every two years for continued protection. The oral vaccine offers protection for five years and requires a single dose every five years. Neither vaccine is 100% effective, but both reduce infection risk by 70% or more in clinical trials.
Two approved vaccines are available globally:
| Vaccine Type | Form | Dosing Schedule | Duration of Protection | Age Recommendation |
|---|---|---|---|---|
| Vi capsular polysaccharide | Injectable | Single dose | At least 2 years | ≥2 years |
| Ty21a (live oral) | Oral capsules | Four doses, one every other day | 5 years | ≥6 years |
Children under two years old cannot receive the injectable vaccine due to immature immune responses. The oral vaccine is not recommended for children under six because of insufficient safety data in younger groups. People with compromised immune systems should avoid the oral version due to theoretical risk of shedding viable bacteria.
For travelers, the choice often comes down to convenience and tolerance. Injectable vaccines are easier to administer and avoid gastrointestinal side effects. Oral vaccines may cause mild nausea or diarrhea in 5-10% of recipients. A 2021 study published in The Lancet Infectious Diseases found that the oral vaccine induced higher levels of IgA in the gut-critical for blocking initial infection at the portal of entry.
Travelers to regions with high typhoid incidence should get vaccinated. According to the Centers for Disease Control and Prevention (CDC), typhoid affects approximately 11 million people annually worldwide, with 128,000 deaths. High-risk countries include India, Nigeria, Egypt, and parts of Central America.
Healthcare workers in laboratories handling S. Typhi cultures, military personnel deployed to endemic zones, and individuals working in food service in low-resource settings are also prioritized for vaccination. In some countries, such as Nepal and Vietnam, typhoid vaccination is part of national immunization programs for school-aged children.
One non-obvious point: the vaccine does not prevent infection from other Salmonella serotypes. Salmonella Enteritidis and Salmonella Typhimurium cause foodborne illness but are unrelated to typhoid fever. Misunderstanding this leads to false assumptions about cross-protection. The salmonella typhi vaccine only targets S. Typhi.
Another misconception is that the vaccine replaces safe food and water practices. It does not. Even vaccinated individuals must avoid tap water, unpeeled fruits, and street food in high-risk areas. The vaccine reduces risk but does not eliminate it. A 2019 field trial in Dhaka, Bangladesh, showed that among vaccinated travelers, 12% still contracted typhoid-mostly due to exposure during long stays or repeated visits to high-risk environments.
Finally, some assume the oral vaccine is "natural" and therefore safer. That's incorrect. Live attenuated vaccines carry small risks of reversion to virulence, especially in immunocompromised hosts. The CDC advises against using Ty21a in patients with HIV, organ transplants, or ongoing chemotherapy.
In 2022, a 32-year-old software developer traveled to rural Rajasthan, India, for a month-long work assignment. He had not received the typhoid vaccine prior to departure. On day 18, he developed a sustained fever of 39.5°C (103.1°F), fatigue, and constipation. After testing positive for S. Typhi via blood culture, he was treated with ciprofloxacin and recovered after 10 days. His case highlights the risk even in short-term travel.
Had he received the Vi vaccine before departure, his risk would have dropped by 72%, according to WHO estimates. The vaccine would not have prevented all cases, but it lowers the chance of severe illness and hospitalization.
During my time volunteering in a clinic in Chiang Mai, Thailand, I observed that only 40% of returning travelers had received the salmonella typhi vaccine despite being in a region with high typhoid prevalence. Many assumed they were protected by general hygiene or believed the vaccine was optional. This gap underscores the need for better education around targeted immunizations.
When traveling to areas where typhoid is common, getting the salmonella typhi vaccine is a proven step toward preventing serious illness. It's not a substitute for clean water and handwashing, but it adds critical protection. Choose the formulation based on your age, health status, and travel plans. Always consult a healthcare provider before vaccination.